-
1
-
-
0022382844
-
Inactivation of viruses in labile blood derivatives: disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations
-
COI: 1:CAS:528:DyaL28Xls1altg%3D%3D, PID: 3934801
-
Horowitz B, Wiebe ME, Lippin A, Stryer MH (1985) Inactivation of viruses in labile blood derivatives: disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations. Transfusion 25:516–522
-
(1985)
Transfusion
, vol.25
, pp. 516-522
-
-
Horowitz, B.1
Wiebe, M.E.2
Lippin, A.3
Stryer, M.H.4
-
2
-
-
0023058814
-
Sterilization of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate
-
COI: 1:CAS:528:DyaL28XitFejtbs%3D, PID: 2870224
-
Prince AM, Horowitz B, Brotman B (1986) Sterilization of hepatitis and HTLV-III viruses by exposure to tri(n-butyl)phosphate and sodium cholate. Lancet 1:706–710
-
(1986)
Lancet
, vol.1
, pp. 706-710
-
-
Prince, A.M.1
Horowitz, B.2
Brotman, B.3
-
3
-
-
69249170993
-
Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Therapeutics Association member companies
-
PID: 19497061
-
Dichtelmüller HO, Biesert L, Fabbrizzi F et al (2009) Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Therapeutics Association member companies. Transfusion 49:1931–1943
-
(2009)
Transfusion
, vol.49
, pp. 1931-1943
-
-
Dichtelmüller, H.O.1
Biesert, L.2
Fabbrizzi, F.3
-
4
-
-
0015258068
-
Characterization of subviral components resulting from treatment of rabies virus with tri(n-buty1)phosphate
-
COI: 1:CAS:528:DyaE38XhsV2ntLc%3D, PID: 5011265
-
Neurath AR, Vernon SK, Dobkin MB, Rubin BA (1972) Characterization of subviral components resulting from treatment of rabies virus with tri(n-buty1)phosphate. J Gen Virol 14:33–48
-
(1972)
J Gen Virol
, vol.14
, pp. 33-48
-
-
Neurath, A.R.1
Vernon, S.K.2
Dobkin, M.B.3
Rubin, B.A.4
-
5
-
-
79952196987
-
Data management and data integration in the HUPO plasma proteome project
-
COI: 1:CAS:528:DC%2BC3cXhsFyjsrnE, PID: 21063952
-
Omenn GS (2011) Data management and data integration in the HUPO plasma proteome project. Methods Mol Biol 696:247–257
-
(2011)
Methods Mol Biol
, vol.696
, pp. 247-257
-
-
Omenn, G.S.1
-
6
-
-
79851482225
-
The use of solvent/detergent treatment in pathogen reduction of plasma
-
PID: 21779207
-
Hellstern P, Solheim BG (2011) The use of solvent/detergent treatment in pathogen reduction of plasma. Transfus Med Hemother 38:65–70
-
(2011)
Transfus Med Hemother
, vol.38
, pp. 65-70
-
-
Hellstern, P.1
Solheim, B.G.2
-
7
-
-
0026669973
-
Manufacture and in vitro characterization of solvent/detergent-treated plasma
-
COI: 1:CAS:528:DyaK3sXksFGmsQ%3D%3D, PID: 1448962
-
Hellstern P, Sachse H, Schwinn H, Oberfrank K (1992) Manufacture and in vitro characterization of solvent/detergent-treated plasma. Vox Sang 63:178–185
-
(1992)
Vox Sang
, vol.63
, pp. 178-185
-
-
Hellstern, P.1
Sachse, H.2
Schwinn, H.3
Oberfrank, K.4
-
8
-
-
0026543642
-
Solvent/detergent-treated plasma. A virus-inactivated substitute for fresh frozen plasma
-
COI: 1:STN:280:DyaK387hvFejuw%3D%3D, PID: 1310064
-
Horowitz B, Bonomo R, Prince AM, Chin SN, Brotman B, Shulman RW (1992) Solvent/detergent-treated plasma. A virus-inactivated substitute for fresh frozen plasma. Blood 79:826–833
-
(1992)
Blood
, vol.79
, pp. 826-833
-
-
Horowitz, B.1
Bonomo, R.2
Prince, A.M.3
Chin, S.N.4
Brotman, B.5
Shulman, R.W.6
-
9
-
-
0031853914
-
Solvent/detergent treatment of human plasma: a very robust method for virus inactivation. Validation of virus safety of Octaplas
-
COI: 1:CAS:528:DyaK1cXkvFCitr8%3D, PID: 9789530
-
Biesert L, Shartono H (1998) Solvent/detergent treatment of human plasma: a very robust method for virus inactivation. Validation of virus safety of Octaplas. Vox Sang 74(Suppl 1):207–212
-
(1998)
Vox Sang
, vol.74
, pp. 207-212
-
-
Biesert, L.1
Shartono, H.2
-
10
-
-
62349127703
-
Properties of pathogen-inactivated plasma components
-
PID: 19304113
-
Prowse C (2009) Properties of pathogen-inactivated plasma components. Transfus Med Rev 23:124–133
-
(2009)
Transfus Med Rev
, vol.23
, pp. 124-133
-
-
Prowse, C.1
-
13
-
-
33751360613
-
A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable bag system
-
COI: 1:CAS:528:DC%2BD2sXns1KmsQ%3D%3D, PID: 17176321
-
Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M (2006) A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable bag system. Transfusion 46:2100–2108
-
(2006)
Transfusion
, vol.46
, pp. 2100-2108
-
-
Burnouf, T.1
Goubran, H.A.2
Radosevich, M.3
Sayed, M.A.4
Gorgy, G.5
El-Ekiaby, M.6
-
14
-
-
74049149907
-
Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system
-
COI: 1:STN:280:DC%2BC3c3kslaitQ%3D%3D, PID: 19778318
-
El-Ekiaby M, Sayed MA, Caron C et al (2010) Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system. Transfus Med 20:48–61
-
(2010)
Transfus Med
, vol.20
, pp. 48-61
-
-
El-Ekiaby, M.1
Sayed, M.A.2
Caron, C.3
-
15
-
-
84883896424
-
Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers
-
COI: 1:CAS:528:DC%2BC3sXhsVCgt7fF, PID: 23320451
-
Jilma-Stohlawetz P, Kursten FW, Horvath M et al (2013) Recovery, safety, and tolerability of a solvent/detergent-treated and prion-safeguarded transfusion plasma in a randomized, crossover, clinical trial in healthy volunteers. Transfusion 53:1906–1917
-
(2013)
Transfusion
, vol.53
, pp. 1906-1917
-
-
Jilma-Stohlawetz, P.1
Kursten, F.W.2
Horvath, M.3
-
16
-
-
70349527966
-
Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time
-
COI: 1:CAS:528:DC%2BD1MXht1OqsL%2FI, PID: 19392784
-
Heger A, Svae TE, Neisser-Svae A, Jordan S, Behizad M, Römisch J (2009) Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time. Vox Sang 97:219–225
-
(2009)
Vox Sang
, vol.97
, pp. 219-225
-
-
Heger, A.1
Svae, T.E.2
Neisser-Svae, A.3
Jordan, S.4
Behizad, M.5
Römisch, J.6
-
17
-
-
47749155632
-
Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma
-
PID: 18661921
-
Liumbruno GM, Sodini ML, Grazzini G, Tuscan Transfusion System (2008) Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma. Blood Transfus 6:25–36
-
(2008)
Blood Transfus
, vol.6
, pp. 25-36
-
-
Liumbruno, G.M.1
Sodini, M.L.2
Grazzini, G.3
Tuscan Transfusion System4
-
18
-
-
0033792014
-
Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma
-
COI: 1:STN:280:DC%2BD3crhtVSrug%3D%3D, PID: 11061856
-
Koenigbauer UF, Eastlund T, Day JW (2000) Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma. Transfusion 40:1203–1206
-
(2000)
Transfusion
, vol.40
, pp. 1203-1206
-
-
Koenigbauer, U.F.1
Eastlund, T.2
Day, J.W.3
-
19
-
-
66349101982
-
Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components
-
PID: 19503628
-
Liumbruno GM, Catalano L, Piccinini V, Pupella S, Grazzini G (2009) Reduction of the risk of bacterial contamination of blood components through diversion of the first part of the donation of blood and blood components. Blood Transfus 7:86–93
-
(2009)
Blood Transfus
, vol.7
, pp. 86-93
-
-
Liumbruno, G.M.1
Catalano, L.2
Piccinini, V.3
Pupella, S.4
Grazzini, G.5
-
20
-
-
84859853766
-
Impact of solvent/detergent treatment of plasma on transfusion-relevant bacteria
-
COI: 1:CAS:528:DC%2BC38Xptl2isbY%3D, PID: 22092109
-
Chou ML, Wu YW, Su CY, Lee LW, Burnouf T (2012) Impact of solvent/detergent treatment of plasma on transfusion-relevant bacteria. Vox Sang 102:277–284
-
(2012)
Vox Sang
, vol.102
, pp. 277-284
-
-
Chou, M.L.1
Wu, Y.W.2
Su, C.Y.3
Lee, L.W.4
Burnouf, T.5
-
21
-
-
0033668693
-
Solvent-detergent fresh frozen plasma. A superior alternative to standard fresh frozen plasma?
-
COI: 1:STN:280:DC%2BD3M7lt1Oiuw%3D%3D, PID: 11139117
-
Sharma AD, Sreeram D, Erb T, Grocott HP (2000) Solvent-detergent fresh frozen plasma. A superior alternative to standard fresh frozen plasma? J Cardiothorac Vasc Anesth 14:712–717
-
(2000)
J Cardiothorac Vasc Anesth
, vol.14
, pp. 712-717
-
-
Sharma, A.D.1
Sreeram, D.2
Erb, T.3
Grocott, H.P.4
-
22
-
-
13544277096
-
Solvent/detergent-treated plasma: composition, efficacy, and safety
-
COI: 1:CAS:528:DC%2BD2cXhtVWktbfL, PID: 15666659
-
Hellstern P (2004) Solvent/detergent-treated plasma: composition, efficacy, and safety. Curr Opin Hematol 11:346–350
-
(2004)
Curr Opin Hematol
, vol.11
, pp. 346-350
-
-
Hellstern, P.1
-
23
-
-
33748475913
-
Update on pathogen reduction technology for therapeutic plasma: an overview
-
COI: 1:STN:280:DC%2BD28rlsFCitg%3D%3D, PID: 16934528
-
Solheim BG, Seghatchian J (2006) Update on pathogen reduction technology for therapeutic plasma: an overview. Transfus Apher Sci 35:83–90
-
(2006)
Transfus Apher Sci
, vol.35
, pp. 83-90
-
-
Solheim, B.G.1
Seghatchian, J.2
-
24
-
-
0026493740
-
Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results
-
COI: 1:STN:280:DyaK3s7islGqsA%3D%3D, PID: 1336258
-
Piquet Y, Janvier G, Selosse P et al (1992) Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results. Vox Sang 63:251–256
-
(1992)
Vox Sang
, vol.63
, pp. 251-256
-
-
Piquet, Y.1
Janvier, G.2
Selosse, P.3
-
25
-
-
9644303469
-
Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas)
-
COI: 1:CAS:528:DC%2BD2MXitFyisQ%3D%3D, PID: 15548265
-
Sinnott P, Bodger S, Gupta A, Brophy M (2004) Presence of HLA antibodies in single-donor-derived fresh frozen plasma compared with pooled, solvent detergent-treated plasma (Octaplas). Eur J Immunogenet 31:271–274
-
(2004)
Eur J Immunogenet
, vol.31
, pp. 271-274
-
-
Sinnott, P.1
Bodger, S.2
Gupta, A.3
Brophy, M.4
-
26
-
-
27744588912
-
White blood cell reactive antibodies are undetectable in solvent/detergent plasma
-
PID: 16181214
-
Sachs UJ, Kauschat D, Bein G (2005) White blood cell reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 45:1628–1631
-
(2005)
Transfusion
, vol.45
, pp. 1628-1631
-
-
Sachs, U.J.1
Kauschat, D.2
Bein, G.3
-
27
-
-
0037293170
-
The Norwegian Plasma Fractionation Project: a 12-year clinical and economic success story
-
COI: 1:STN:280:DC%2BD3s7gvVyqsg%3D%3D, PID: 12620274
-
Flesland O, Seghatchian J, Solheim BG (2003) The Norwegian Plasma Fractionation Project: a 12-year clinical and economic success story. Transfus Apher Sci 28:93–100
-
(2003)
Transfus Apher Sci
, vol.28
, pp. 93-100
-
-
Flesland, O.1
Seghatchian, J.2
Solheim, B.G.3
-
28
-
-
84888432559
-
Eight years with haemovigilance in Norway. What have we learnt?
-
PID: 24157220
-
Steinsvåg CT, Espinosa A, Flesland O (2013) Eight years with haemovigilance in Norway. What have we learnt? Transfus Apher Sci 49:548–552
-
(2013)
Transfus Apher Sci
, vol.49
, pp. 548-552
-
-
Steinsvåg, C.T.1
Espinosa, A.2
Flesland, O.3
-
29
-
-
84878249988
-
Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS: a pilot study
-
COI: 1:CAS:528:DC%2BC3sXhtV2rtr4%3D, PID: 23338984
-
Thevis M, Krug O, Geyer H et al (2013) Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS: a pilot study. Drug Test Anal 5:380–383
-
(2013)
Drug Test Anal
, vol.5
, pp. 380-383
-
-
Thevis, M.1
Krug, O.2
Geyer, H.3
-
30
-
-
78049266816
-
Anaerobic storage of red blood cells
-
PID: 20967163
-
Yoshida T, Shevkoplyas SS (2010) Anaerobic storage of red blood cells. Blood Transfus 8:220–236
-
(2010)
Blood Transfus
, vol.8
, pp. 220-236
-
-
Yoshida, T.1
Shevkoplyas, S.S.2
-
31
-
-
84898816839
-
Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion
-
COI: 1:CAS:528:DC%2BC2cXmvV2js74%3D, PID: 24460692
-
Feys HB, Van Aelst B, Devreese K et al (2014) Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion. Vox Sang 106:307–315
-
(2014)
Vox Sang
, vol.106
, pp. 307-315
-
-
Feys, H.B.1
Van Aelst, B.2
Devreese, K.3
-
32
-
-
84880703877
-
Update on the use of pathogen-reduced human plasma and platelet concentrates
-
COI: 1:CAS:528:DC%2BC3sXhtFOitrnN, PID: 23710899
-
Seltsam A, Müller TH (2013) Update on the use of pathogen-reduced human plasma and platelet concentrates. Br J Haematol 162:442–454
-
(2013)
Br J Haematol
, vol.162
, pp. 442-454
-
-
Seltsam, A.1
Müller, T.H.2
-
33
-
-
52049111879
-
Quality control of recovered plasma for fractionation: an extensive Italian study
-
COI: 1:CAS:528:DC%2BD1cXpt1emsLY%3D, PID: 18435675
-
Grazzini G, Rossi G, Rafanelli D et al (2008) Quality control of recovered plasma for fractionation: an extensive Italian study. Transfusion 48:1459–1468
-
(2008)
Transfusion
, vol.48
, pp. 1459-1468
-
-
Grazzini, G.1
Rossi, G.2
Rafanelli, D.3
-
34
-
-
33847616443
-
Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development
-
COI: 1:CAS:528:DC%2BD2sXkvFens7w%3D, PID: 17348869
-
Heger A, Kannicht C, Römisch J, Svae TE (2007) Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development. Vox Sang 92:206–212
-
(2007)
Vox Sang
, vol.92
, pp. 206-212
-
-
Heger, A.1
Kannicht, C.2
Römisch, J.3
Svae, T.E.4
-
36
-
-
0037379294
-
Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP/Octaplas)
-
PID: 12651690, author reply 1231–1232
-
Solheim BG, Bergan A, Brosstad F, Innes R, Svennevig JL (2003) Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP/Octaplas). Anesth Analg 96:1230–1231 author reply 1231–1232
-
(2003)
Anesth Analg
, vol.96
, pp. 1230-1231
-
-
Solheim, B.G.1
Bergan, A.2
Brosstad, F.3
Innes, R.4
Svennevig, J.L.5
-
37
-
-
0031823643
-
In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma
-
COI: 1:CAS:528:DyaK1cXkvFCitr0%3D, PID: 9789532
-
Beeck H, Hellstern P (1998) In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma. Vox Sang 74(Suppl 1):219–223
-
(1998)
Vox Sang
, vol.74
, pp. 219-223
-
-
Beeck, H.1
Hellstern, P.2
-
38
-
-
34249717261
-
Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas)
-
PID: 17544896
-
Magner JJ, Crowley KJ, Boylan JF (2007) Fatal fibrinolysis during orthotopic liver transplantation in patients receiving solvent/detergent-treated plasma (Octaplas). J Cardiothorac Vasc Anesth 21:410–413
-
(2007)
J Cardiothorac Vasc Anesth
, vol.21
, pp. 410-413
-
-
Magner, J.J.1
Crowley, K.J.2
Boylan, J.F.3
-
39
-
-
34848864313
-
It is time to bring back solvent-detergent plasma
-
PID: 17898568
-
Sandler SG (2007) It is time to bring back solvent-detergent plasma. Curr Opin Hematol 14:640–641
-
(2007)
Curr Opin Hematol
, vol.14
, pp. 640-641
-
-
Sandler, S.G.1
-
40
-
-
33746460956
-
Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe?
-
COI: 1:STN:280:DC%2BD28vlslKltQ%3D%3D, PID: 16879155
-
Salge-Bartels U, Breitner-Ruddock S, Hunfeld A, Seitz R, Heiden M (2006) Are quality differences responsible for different adverse reactions reported for SD-plasma from USA and Europe? Transfus Med 16:266–275
-
(2006)
Transfus Med
, vol.16
, pp. 266-275
-
-
Salge-Bartels, U.1
Breitner-Ruddock, S.2
Hunfeld, A.3
Seitz, R.4
Heiden, M.5
-
41
-
-
2942624020
-
Acute hyperphosphatemia after plasma exchange with S/D-treated plasma
-
PID: 15157269
-
Thiéry G, Jacobs F, Bussel A et al (2004) Acute hyperphosphatemia after plasma exchange with S/D-treated plasma. Transfusion 44:947–948
-
(2004)
Transfusion
, vol.44
, pp. 947-948
-
-
Thiéry, G.1
Jacobs, F.2
Bussel, A.3
-
42
-
-
0033857903
-
Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?
-
COI: 1:STN:280:DC%2BD3cvlvVGhtw%3D%3D, PID: 10962468
-
Flamholz R, Jeon HR, Baron JM, Baron BW (2000) Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses? J Clin Apher 15:169–172
-
(2000)
J Clin Apher
, vol.15
, pp. 169-172
-
-
Flamholz, R.1
Jeon, H.R.2
Baron, J.M.3
Baron, B.W.4
-
43
-
-
0037600705
-
Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura
-
PID: 12780794
-
Yarranton H, Cohen H, Pavord SR, Benjamin S, Hagger D, Machin SJ (2003) Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura. Br J Haematol 121:778–785
-
(2003)
Br J Haematol
, vol.121
, pp. 778-785
-
-
Yarranton, H.1
Cohen, H.2
Pavord, S.R.3
Benjamin, S.4
Hagger, D.5
Machin, S.J.6
-
44
-
-
0033843210
-
Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura–haemolytic–uremic syndrome
-
COI: 1:STN:280:DC%2BD3cvjtFKmsw%3D%3D, PID: 10960513
-
Rizvi MA, Vesely JN, George JN et al (2000) Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura–haemolytic–uremic syndrome. Transfusion 40:896–901
-
(2000)
Transfusion
, vol.40
, pp. 896-901
-
-
Rizvi, M.A.1
Vesely, J.N.2
George, J.N.3
-
45
-
-
0037342954
-
Complications of plasma exchange in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: a study of 78 additional patients
-
PID: 12675731
-
McMinn JR Jr, Thomas IA, Terrel DR, Duvall D, Vesely SK, George JN (2003) Complications of plasma exchange in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: a study of 78 additional patients. Transfusion 43:415–416
-
(2003)
Transfusion
, vol.43
, pp. 415-416
-
-
McMinn, J.R.1
Thomas, I.A.2
Terrel, D.R.3
Duvall, D.4
Vesely, S.K.5
George, J.N.6
-
46
-
-
78651284022
-
A comparison of methods of pathogen inactivation of FFP
-
COI: 1:CAS:528:DC%2BC3MXisV2muro%3D, PID: 20667071
-
Rock G (2011) A comparison of methods of pathogen inactivation of FFP. Vox Sang 100:169–178
-
(2011)
Vox Sang
, vol.100
, pp. 169-178
-
-
Rock, G.1
-
47
-
-
84882303170
-
Current methods for the reduction of blood-borne pathogens: a comprehensive literature review
-
PID: 23522896
-
Picker SM (2013) Current methods for the reduction of blood-borne pathogens: a comprehensive literature review. Blood Transfus 11:343–348
-
(2013)
Blood Transfus
, vol.11
, pp. 343-348
-
-
Picker, S.M.1
-
48
-
-
84861119185
-
Plasma components: properties, differences, and uses
-
COI: 1:CAS:528:DC%2BC38XpvVSitrY%3D, PID: 22578375
-
Benjamin RJ, McLaughlin LS (2012) Plasma components: properties, differences, and uses. Transfusion 52(Suppl):9S–19S
-
(2012)
Transfusion
, vol.52
, pp. 9S-19S
-
-
Benjamin, R.J.1
McLaughlin, L.S.2
-
49
-
-
84859837359
-
Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmas
-
COI: 1:CAS:528:DC%2BC38Xptl2itrk%3D, PID: 22092160
-
Hacquard M, Lecompte T, Belcour B et al (2012) Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmas. Vox Sang 102:354–361
-
(2012)
Vox Sang
, vol.102
, pp. 354-361
-
-
Hacquard, M.1
Lecompte, T.2
Belcour, B.3
-
50
-
-
33746572800
-
Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
-
COI: 1:CAS:528:DC%2BD28XnsFartbY%3D, PID: 16836564
-
Singh Y, Sawyer LS, Pinkoski LS et al (2006) Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 46:1168–1177
-
(2006)
Transfusion
, vol.46
, pp. 1168-1177
-
-
Singh, Y.1
Sawyer, L.S.2
Pinkoski, L.S.3
-
51
-
-
77950239200
-
Protein quality in Mirasol pathogen reduction technology–treated, apheresis-derived fresh-frozen plasma
-
COI: 1:CAS:528:DC%2BC3cXls12ltb8%3D, PID: 20051060
-
Smith J, Rock G (2010) Protein quality in Mirasol pathogen reduction technology–treated, apheresis-derived fresh-frozen plasma. Transfusion 50:926–931
-
(2010)
Transfusion
, vol.50
, pp. 926-931
-
-
Smith, J.1
Rock, G.2
-
52
-
-
0034490673
-
The effect of virus inactivation on coagulation factors in therapeutic plasma
-
COI: 1:STN:280:DC%2BD3M7hvFWisA%3D%3D, PID: 11122166
-
Zeiler T, Wittmann G, Zimmermann R, Hintz G, Huhn D, Riess H (2000) The effect of virus inactivation on coagulation factors in therapeutic plasma. Br J Haematol 111:986–987
-
(2000)
Br J Haematol
, vol.111
, pp. 986-987
-
-
Zeiler, T.1
Wittmann, G.2
Zimmermann, R.3
Hintz, G.4
Huhn, D.5
Riess, H.6
-
53
-
-
0038057391
-
Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma
-
COI: 1:CAS:528:DC%2BD3sXivFSitrg%3D, PID: 12695752
-
Doyle S, O’Brien P, Murphy K, Fleming C, O’Donnell J (2003) Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma. Blood Coagul Fibrinolysis 14:283–287
-
(2003)
Blood Coagul Fibrinolysis
, vol.14
, pp. 283-287
-
-
Doyle, S.1
O’Brien, P.2
Murphy, K.3
Fleming, C.4
O’Donnell, J.5
-
54
-
-
0032776380
-
Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma
-
COI: 1:CAS:528:DyaK1MXkvFaksbk%3D, PID: 10413283
-
Aznar JA, Molina R, Montoro JM (1999) Factor VIII/von Willebrand factor complex in methylene blue-treated fresh plasma. Transfusion 39:748–750
-
(1999)
Transfusion
, vol.39
, pp. 748-750
-
-
Aznar, J.A.1
Molina, R.2
Montoro, J.M.3
-
55
-
-
37549049779
-
Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen
-
COI: 1:CAS:528:DC%2BD1cXisVygtL0%3D, PID: 17900283
-
Osselaer JC, Debry C, Goffaux M et al (2008) Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 48:108–117
-
(2008)
Transfusion
, vol.48
, pp. 108-117
-
-
Osselaer, J.C.1
Debry, C.2
Goffaux, M.3
-
56
-
-
1842715059
-
Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura
-
COI: 1:STN:280:DC%2BD2c7lt1CitQ%3D%3D, PID: 15043592
-
Yarranton H, Lawrie AS, Purdy G, Mackie IJ, Machin SJ (2004) Comparison of von Willebrand factor antigen, von Willebrand factor-cleaving protease and protein S in blood components used for treatment of thrombotic thrombocytopenic purpura. Transfus Med 14:39–44
-
(2004)
Transfus Med
, vol.14
, pp. 39-44
-
-
Yarranton, H.1
Lawrie, A.S.2
Purdy, G.3
Mackie, I.J.4
Machin, S.J.5
-
57
-
-
41149163375
-
Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers
-
COI: 1:CAS:528:DC%2BD1cXltlWiu78%3D, PID: 18194378
-
Schlenke P, Hervig T, Isola H et al (2008) Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers. Transfusion 48:697–705
-
(2008)
Transfusion
, vol.48
, pp. 697-705
-
-
Schlenke, P.1
Hervig, T.2
Isola, H.3
-
58
-
-
71549147205
-
The influence of riboflavin photochemistry on plasma coagulation factors
-
PID: 19782644
-
Larrea L, Calabuig M, Roldan V et al (2009) The influence of riboflavin photochemistry on plasma coagulation factors. Transfus Apher Sci 41:199–204
-
(2009)
Transfus Apher Sci
, vol.41
, pp. 199-204
-
-
Larrea, L.1
Calabuig, M.2
Roldan, V.3
-
59
-
-
0027326230
-
Evaluation of solvent/detergent treated plasma in the management of patients with acquired coagulation disorders
-
Inbal A, Epstein O, Blickstein D, Kombrot N, Brenner B, Martinowitz U (1993) Evaluation of solvent/detergent treated plasma in the management of patients with acquired coagulation disorders. Blood Coagul Fibrinolysis 4:559–604
-
(1993)
Blood Coagul Fibrinolysis
, vol.4
, pp. 559-604
-
-
Inbal, A.1
Epstein, O.2
Blickstein, D.3
Kombrot, N.4
Brenner, B.5
Martinowitz, U.6
-
60
-
-
0031850598
-
SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available
-
COI: 1:CAS:528:DyaK1cXkvFCitrs%3D, PID: 9789534
-
Horowitz MS, Pehta JC (1998) SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sang 74(Suppl 1):231–235
-
(1998)
Vox Sang
, vol.74
, pp. 231-235
-
-
Horowitz, M.S.1
Pehta, J.C.2
-
61
-
-
33744499442
-
Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy
-
PID: 16670069
-
Santagostino E, Mancuso ME, Morfini M et al (2006) Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders: dosing, pharmacokinetics and clinical efficacy. Haematologica 91:634–639
-
(2006)
Haematologica
, vol.91
, pp. 634-639
-
-
Santagostino, E.1
Mancuso, M.E.2
Morfini, M.3
-
62
-
-
1842610163
-
Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients
-
PID: 15015971
-
Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125:69–73
-
(2004)
Br J Haematol
, vol.125
, pp. 69-73
-
-
Chowdhury, P.1
Saayman, A.G.2
Paulus, U.3
Findlay, G.P.4
Collins, P.W.5
-
63
-
-
33745783733
-
Toward rational fresh frozen plasma transfusion
-
PID: 16753596
-
Holland LL, Brooks JP (2006) Toward rational fresh frozen plasma transfusion. Am J Clin Pathol 126:133–139
-
(2006)
Am J Clin Pathol
, vol.126
, pp. 133-139
-
-
Holland, L.L.1
Brooks, J.P.2
-
64
-
-
61849136778
-
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
-
COI: 1:STN:280:DC%2BD1M3hsVWltQ%3D%3D, PID: 19222477
-
Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 145:24–33
-
(2009)
Br J Haematol
, vol.145
, pp. 24-33
-
-
Levi, M.1
Toh, C.H.2
Thachil, J.3
Watson, H.G.4
-
65
-
-
78751505594
-
Recommendations for the transfusion management of patients in the peri-operative period I. The pre-operative period
-
PID: 21235852
-
Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party (2011) Recommendations for the transfusion management of patients in the peri-operative period I. The pre-operative period. Blood Transfus 9:19–40
-
(2011)
Blood Transfus
, vol.9
, pp. 19-40
-
-
Liumbruno, G.M.1
Bennardello, F.2
Lattanzio, A.3
Piccoli, P.4
Rossetti, G.5
Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party6
-
66
-
-
79953745541
-
Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period
-
PID: 21527082
-
Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party (2011) Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period. Blood Transfus 9:189–217
-
(2011)
Blood Transfus
, vol.9
, pp. 189-217
-
-
Liumbruno, G.M.1
Bennardello, F.2
Lattanzio, A.3
Piccoli, P.4
Rossetti, G.5
Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party6
-
67
-
-
0033674115
-
Evaluation of solvent/detergent treated plasma in patients with a prolonged prothrombin time
-
COI: 1:CAS:528:DC%2BD3cXptVeiurw%3D, PID: 11111235
-
Lerner RG, Nelson J, Sorcia E (2000) Evaluation of solvent/detergent treated plasma in patients with a prolonged prothrombin time. Vox Sang 79:161–167
-
(2000)
Vox Sang
, vol.79
, pp. 161-167
-
-
Lerner, R.G.1
Nelson, J.2
Sorcia, E.3
-
68
-
-
0034095642
-
Comparison of solvent/detergent-inactivated plasma and fresh frozen plasma under routine clinical conditions
-
PID: 10878483
-
Beck KH, Mortelsmans Y, Kretschmer VV, Höltermann W, Lukasewitz P (2000) Comparison of solvent/detergent-inactivated plasma and fresh frozen plasma under routine clinical conditions. Infusionsther Transfusionsmed 27:144–148
-
(2000)
Infusionsther Transfusionsmed
, vol.27
, pp. 144-148
-
-
Beck, K.H.1
Mortelsmans, Y.2
Kretschmer, V.V.3
Höltermann, W.4
Lukasewitz, P.5
-
69
-
-
0032740602
-
A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation
-
COI: 1:STN:280:DC%2BD3c%2FmslOguw%3D%3D, PID: 10604250
-
Williamson LM, Llewelyn CA, Fisher NC et al (1999) A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion 39:1227–1234
-
(1999)
Transfusion
, vol.39
, pp. 1227-1234
-
-
Williamson, L.M.1
Llewelyn, C.A.2
Fisher, N.C.3
-
70
-
-
33749361738
-
Universal pathogen-reduced plasma in elective open-heart surgery and liver resection
-
PID: 16988101
-
Solheim BG (2006) Universal pathogen-reduced plasma in elective open-heart surgery and liver resection. Clin Med Res 4:209–217
-
(2006)
Clin Med Res
, vol.4
, pp. 209-217
-
-
Solheim, B.G.1
-
71
-
-
20544468386
-
Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection
-
COI: 1:STN:280:DC%2BD2M3psVCktw%3D%3D, PID: 15938736
-
Solheim BG, Granov DA, Juravlev VA et al (2005) Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resection. Vox Sang 89:19–26
-
(2005)
Vox Sang
, vol.89
, pp. 19-26
-
-
Solheim, B.G.1
Granov, D.A.2
Juravlev, V.A.3
-
72
-
-
33745001461
-
Solvent–detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies
-
COI: 1:STN:280:DC%2BD283hvVaqsg%3D%3D, PID: 16623914
-
Chekrizova V, Murphy WG (2006) Solvent–detergent plasma: use in neonatal patients, in adult and paediatric patients with liver disease and in obstetric and gynaecological emergencies. Transfus Med 16:85–91
-
(2006)
Transfus Med
, vol.16
, pp. 85-91
-
-
Chekrizova, V.1
Murphy, W.G.2
-
73
-
-
7344246551
-
A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation
-
COI: 1:CAS:528:DyaK1cXkvFCitro%3D, PID: 9789533
-
Freeman JW, Williamson LM, Llewelyn C et al (1998) A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during orthotopic liver transplantation. Vox Sang 74(Suppl 1):225–229
-
(1998)
Vox Sang
, vol.74
, pp. 225-229
-
-
Freeman, J.W.1
Williamson, L.M.2
Llewelyn, C.3
-
74
-
-
84880298407
-
Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: a prospective randomized control study
-
COI: 1:CAS:528:DC%2BC3sXhtFSrurnO, PID: 23448618
-
Bindi ML, Miccoli M, Marietta M et al (2013) Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: a prospective randomized control study. Vox Sang 105:137–143
-
(2013)
Vox Sang
, vol.105
, pp. 137-143
-
-
Bindi, M.L.1
Miccoli, M.2
Marietta, M.3
-
75
-
-
84876368074
-
Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy
-
PID: 23548954
-
Lepri D, Capuzzo E, Mattioli AV et al (2013) Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy. Recenti Prog Med 104:106–111
-
(2013)
Recenti Prog Med
, vol.104
, pp. 106-111
-
-
Lepri, D.1
Capuzzo, E.2
Mattioli, A.V.3
-
76
-
-
0002371605
-
Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery
-
COI: 1:CAS:528:DC%2BD38Xht1Wltbg%3D, PID: 11856461
-
Haubelt H, Blome M, Kiessling AH et al (2002) Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sang 82:9–14
-
(2002)
Vox Sang
, vol.82
, pp. 9-14
-
-
Haubelt, H.1
Blome, M.2
Kiessling, A.H.3
-
77
-
-
0010692251
-
Prospective randomized and controlled study on solvent/detergent versus methylene blue/light virus-inactivated plasma
-
Wieding JU, Rathgeber J, Zenker D (1999) Prospective randomized and controlled study on solvent/detergent versus methylene blue/light virus-inactivated plasma. Transfusion 39(S10):23s. doi:10.1111/j.1537-2995.1999.tb05925.x
-
(1999)
Transfusion
, vol.39
, Issue.S10
, pp. 23s
-
-
Wieding, J.U.1
Rathgeber, J.2
Zenker, D.3
-
78
-
-
0242677709
-
Universal fresh frozen plasma (Uniplas): a safe product in open-heart surgery
-
PID: 12955185
-
Tollofsrud S, Noddeland H, Svennevig JL, Bentsen G, Mollnes TE, Solheim BG (2003) Universal fresh frozen plasma (Uniplas): a safe product in open-heart surgery. Intensive Care Med 29:1736–1743
-
(2003)
Intensive Care Med
, vol.29
, pp. 1736-1743
-
-
Tollofsrud, S.1
Noddeland, H.2
Svennevig, J.L.3
Bentsen, G.4
Mollnes, T.E.5
Solheim, B.G.6
-
79
-
-
47749153754
-
Virus-inactivated—Plasmasafe: a one-year experience
-
PID: 19204766
-
De Silvestro G, Bagatella P, Tison T et al (2007) Virus-inactivated—Plasmasafe: a one-year experience. Blood Transfus 5:134–142
-
(2007)
Blood Transfus
, vol.5
, pp. 134-142
-
-
De Silvestro, G.1
Bagatella, P.2
Tison, T.3
-
80
-
-
33644652926
-
The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma
-
PID: 16512839
-
McCarthy LJ (2006) The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma. Br J Haematol 133:107
-
(2006)
Br J Haematol
, vol.133
, pp. 107
-
-
McCarthy, L.J.1
-
81
-
-
34547808148
-
Cryosupernatant and solvent detergent fresh frozen plasma (octaplas) usage in a single centre in acute thrombotic thrombocytopenic purpura
-
COI: 1:STN:280:DC%2BD2svmsFWmtg%3D%3D, PID: 17683359
-
Scully M, Longair I, Flynn M, Berryman J, Machin SJ (2007) Cryosupernatant and solvent detergent fresh frozen plasma (octaplas) usage in a single centre in acute thrombotic thrombocytopenic purpura. Vox Sang 93:154–158
-
(2007)
Vox Sang
, vol.93
, pp. 154-158
-
-
Scully, M.1
Longair, I.2
Flynn, M.3
Berryman, J.4
Machin, S.J.5
-
82
-
-
77149138606
-
Efficacy and safety profile of solvent/detergent plasma in the treatment of acute thrombotic thrombocytopenic purpura: a single-center experience
-
PID: 20737012
-
Edel E, Al-Ali HK, Seeger S, Kauschat D, Matthes G (2010) Efficacy and safety profile of solvent/detergent plasma in the treatment of acute thrombotic thrombocytopenic purpura: a single-center experience. Transfus Med Hemother 37:13–19
-
(2010)
Transfus Med Hemother
, vol.37
, pp. 13-19
-
-
Edel, E.1
Al-Ali, H.K.2
Seeger, S.3
Kauschat, D.4
Matthes, G.5
-
83
-
-
79851483728
-
France: solvent/detergent plasma
-
AuBuchon JP, Prowse CV, (eds), AABB Press, Bethesda:
-
Andreu G (2010) France: solvent/detergent plasma. In: AuBuchon JP, Prowse CV (eds) Pathogen inactivation: the penultimate paradigm shift. AABB Press, Bethesda, pp 137–151
-
(2010)
Pathogen inactivation: the penultimate paradigm shift
, pp. 137-151
-
-
Andreu, G.1
-
84
-
-
79851472202
-
Introduction of octaplas in clinical use decreased the rate of serious adverse reactions
-
Krusius T, Auvinen M-K, Tuimala (2010) Introduction of octaplas in clinical use decreased the rate of serious adverse reactions. Vox Sang 99(Suppl 1):P-1018
-
(2010)
Vox Sang
, vol.99
-
-
Krusius, T.1
Auvinen, M.-K.2
Tuimala3
-
85
-
-
0031854171
-
Hemovigilance: clinical tolerance of solvent-detergent treated plasma
-
Baudoux E, Margraff U, Coenen A et al (1998) Hemovigilance: clinical tolerance of solvent-detergent treated plasma. Vox Sang 74Ssuppl 1):237-239
-
(1998)
Vox Sang 74Ssuppl
, vol.1
, pp. 237-239
-
-
Baudoux, E.1
Margraff, U.2
Coenen, A.3
-
86
-
-
84885419540
-
Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety
-
PID: 24032719
-
Bolton-Maggs PH, Cohen H (2013) Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Br J Haematol 163:303–314
-
(2013)
Br J Haematol
, vol.163
, pp. 303-314
-
-
Bolton-Maggs, P.H.1
Cohen, H.2
-
87
-
-
84939918482
-
-
Österreichisches Bundesinstitut für Gesundheitswesen (2004) Hämovigilanz Jahresbericht 2004. Accessed 18 February 2014
-
Österreichisches Bundesinstitut für Gesundheitswesen (2004) Hämovigilanz Jahresbericht 2004. http://www.goeg.at/cxdata/media/download/berichte/HaemJB_2004.pdf. Accessed 18 February 2014
-
-
-
-
88
-
-
84929076517
-
I dati italiani di emovigilanza
-
Facco G, Pupella S, Piccinini V, Catalano L, Vaglio S (2012) I dati italiani di emovigilanza. Blood Transfus 10(Suppl 1):s57–s58
-
(2012)
Blood Transfus
, vol.10
, pp. s57-s58
-
-
Facco, G.1
Pupella, S.2
Piccinini, V.3
Catalano, L.4
Vaglio, S.5
-
89
-
-
84942949484
-
Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply
-
COI: 1:STN:280:DyaK2M%2FhvV2huw%3D%3D, PID: 7933351
-
AuBuchon JP, Birkmeyer JD (1994) Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply. JAMA 272:1210–1214
-
(1994)
JAMA
, vol.272
, pp. 1210-1214
-
-
AuBuchon, J.P.1
Birkmeyer, J.D.2
-
90
-
-
0032903262
-
Cost-effectiveness of transfusing virus inactivated plasma instead of standard plasma
-
COI: 1:STN:280:DyaK1M3mslShug%3D%3D, PID: 10335997
-
Pereira A (1999) Cost-effectiveness of transfusing virus inactivated plasma instead of standard plasma. Transfusion 39:479–487
-
(1999)
Transfusion
, vol.39
, pp. 479-487
-
-
Pereira, A.1
-
91
-
-
0033612672
-
Update of cost-effectiveness analysis for solvent-detergent-treated plasma
-
Jakson BR, AuBuchon JP, Birkmeyer JD (1999) Update of cost-effectiveness analysis for solvent-detergent-treated plasma. JAMA 282:329
-
(1999)
JAMA
, vol.282
, pp. 329
-
-
Jakson, B.R.1
AuBuchon, J.P.2
Birkmeyer, J.D.3
-
92
-
-
0041639518
-
Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma
-
COI: 1:STN:280:DC%2BD3szovV2isA%3D%3D, PID: 12925160
-
Riedler GF, Haycox AR, Duggan AK, Dakin HA (2003) Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma. Vox Sang 85:88–95
-
(2003)
Vox Sang
, vol.85
, pp. 88-95
-
-
Riedler, G.F.1
Haycox, A.R.2
Duggan, A.K.3
Dakin, H.A.4
-
94
-
-
84939918483
-
-
Membe SK, Coyle D, Husereau D, Cimon K, Tinmouth A, Normandin S (2009) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis. Accessed 17 February 2014
-
Membe SK, Coyle D, Husereau D, Cimon K, Tinmouth A, Normandin S (2009) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis. http://www.cadth.ca/media/pdf/I4002_Octaplas%20versus%20FFP_L4_e_April%202009.pdf. Accessed 17 February 2014
-
-
-
|